Quick Search
Filters Clear All
Any Time
- 2026
- 2025
- 2024
- 2023
- 2022
- 2021
- 2020
- 2019
- 2018
- 2017
- 2016
- 2015
- 2014
Product Category
- Antibiotics
- Balanced Salt Solutions
- Cell Dissociation Reagents
- Cell Freezing Media
- Cell Health Assays
- Cell Identification Service
- Cell Lines
- Complete Growth Media
- Cytokines
- Exosome Isolation Kits
- Growth Supplements
- Induced Differentiation Media
- Liquid Basal Media
- Other Reagents
- Powder Basal Media
- Primary Cell Isolation and Culture Kit
- Primary Cells
- Removal Media
- Removal Reagents
- Serum
- Serum-Free Media
Country
- Angola
- Argentina
- Australia
- Austria
- Bangladesh
- Barbados
- Belarus
- Belgium
- Brazil
- Bulgaria
- Burkina Faso
- Burundi
- Cambodia
- Cameroon
- Canada
- Chile
- China
- Chinese Taiwan
- Congo
- Croatia
- Cyprus
- Czech
- Czechia
- Denmark
- Egypt
- Estonia
- Ethiopia
- Finland
- France
- Gabon
- Germany
- Ghana
- Greece
- Hungary
- India
- Indonesia
- Iran
- Iraq
- Ireland
- Israel
- Italy
- Japan
- Kazakhstan
- Kenya
- Korea
- Kuwait
- Kyrgyzstan
- Luxembourg
- Malaysia
- Mexico
- Mongolia
- Morocco
- Mozambique
- Myanmar
- Nepal
- Netherlands
- New Zealand
- Nigeria
- Norway
- Pakistan
- Philippines
- Poland
- Portugal
- Romania
- Russia
- Saudi Arabia
- Singapore
- Slovenia
- Somalia
- South Africa
- South Korea
- Spain
- Sri Lanka
- Sudan
- Sweden
- Switzerland
- Syria
- Thailand
- Tunisia
- Turkey
- UAE
- UK
- USA
- Uganda
- Ukraine
- United Kingdom
- Uruguay
- Uzbekistan
- Vietnam
Publications
Procell has assisted our customers in publishing 32,193 papers in SCI-indexed journals, including leading journals such as Nature Medicine, Nature, Cell, Science, and Signal Transduction and Targeted Therapy.
Filter
-
GBP2 enhances anti–PD-L1 response in colorectal cancer via GSDMD-mediated YAP nuclear translocation by non-pyroptotic (2026-05-11)
-
NDRG2 orchestrates circadian clock stability to suppress tumorigenesis and potentiate oxaliplatin response in colorectal cancer (2026-05-19)
-
MST4 plays dual roles in lung adenocarcinoma by regulating homeostasis of wild-type and mutant p53 protein (2026-05-27)
Journal: ONCOGENE (2026) IF: 9.1Products Cited: DMEM (High glucose) Medium, Fetal Bovine Serum -
Histone methyltransferase KMT2D promotes castration-resistant prostate cancer progression by reactivating AR through FOXA1 (2026-05-30)
-
TIA1 depletion enhances CLSTN1 exon 11 inclusion to facilitate Epithelial-to-Mesenchymal transition and breast cancer metastasis (2026-06-01)
Journal: ONCOGENE (2026) IF: 9.1 -
MCM2 germline variants predispose to familial papillary thyroid carcinoma due to genomic instability caused by MCM complex disruption (2026-06-18)
-
LCAL4–FUS cooperation switches on MMP13 and drives osteolytic bone metastasis in breast cancer (2026-06-18)
Journal: ONCOGENE (2026) IF: 9.1Products Cited: RAW 264.7 Cell Complete Medium, MDA-MB-231 (L15) Cell Complete Medium, MDA-MB-361 (L15) Cell Complete Medium, MCF 10A Cell Complete Medium, E0771 Cell Complete Medium, BT-549 Cell Complete Medium, 293T Cell Complete Medium, T-47D Cell Complete Medium, BT-474 Cell Complete Medium, SUM159PT Cell Complete Medium, MCF7 Cell Complete Medium -
MOV10 suppresses circRNA biogenesis by disrupting reverse complementary matches structure to drive hepatocarcinogenesis (2026-06-21)
Journal: ONCOGENE (2026) IF: 9.1Products Cited: THLE-2 Cell Complete Medium -
Targeting of solute carrier family 1 member 1 that links metabolic reprogramming and ferroptosis sensitivity in pancreatic ductal adenocarcinoma (2026-07-10)
-
CAF-derived exosomes inhibit ferroptosis via GALNT14-mediated O-GalNAcylation of SLC7A11 in colorectal cancer (2026-07-07)
Journal: ONCOGENE (2026) IF: 9.1Products Cited: McCoy's 5A Complete Medium (10), LoVo Cell Complete Medium
